Analyst	Recommendation	Action	Price target	Projected	Date
Damon Delmonte KBW	Hold	Reiterated	$67.00	+15.6%	07/28/2026
Terry McEvoy Stephens	Hold	Reiterated	$66.00	+13.8%	01/27/2026
Brendan Nosal Hovde Group	Hold	Downgraded	-	-	01/07/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	67.03M	69.80M	67.71M	69.16M
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	31.17M	30.26M	31.55M	31.27M
Operating expense	34.09M	32.60M	34.28M	33.58M
Total operating expenses	34.09M	32.60M	34.28M	33.58M
Operating income	32.94M	37.20M	33.43M	35.59M
Other non operating income	-878.00K	-844.00K	-873.00K	-881.00K
EBT including unusual items	32.06M	36.35M	32.56M	34.71M
EBT excluding unusual items	32.06M	36.35M	32.56M	34.71M
Income tax expense	5.66M	6.44M	6.08M	6.27M
Effective tax rate	17.65%	17.73%	18.67%	18.06%
Other operating expenses	2.92M	2.34M	2.73M	2.30M
Net income	26.40M	29.91M	26.48M	28.44M
Net profit margin	39.39%	42.85%	39.11%	41.12%
Earnings per share	1.03	1.16	1.04	1.13
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-151.00K	-451.00K	-155.00K	-176.00K

Ask anything